Argenx SE
Overview
Argenx SE is a global biotechnology company developing a pipeline of antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The company leverages its suite of cutting-edge antibody technologies to engage novel targets and create immunotherapeutic solutions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Argenx SE in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Argenx SE?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.